MFDS
- Marketing authorisation holder: GLAND
- Status: likely_approved
🇰🇷 Angiotensin Ii in South Korea
Angiotensin Ii (ANGIOTENSIN) regulatory status in South Korea.
Marketing authorisation
Angiotensin Ii in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Angiotensin Ii approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Angiotensin Ii in South Korea?
GLAND holds the South Korean marketing authorisation.